Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Antonio Belinchon
Observed name:
Antonio BELINCHÓN-DIEGO
Institutions:
Complejo Hospitalario Universitario de Albacete,
University of Castilla-La Mancha
Observed institutions:
Complejo Hospitalario Universitario de Albacete,
University of Castilla-La Mancha
ORCID:
0000-0002-9285-5860
Observed ORCID:
0000-0002-9285-5860
OpenAlex ID:
A5047915653
Hearing assessment in Menière's disease
2011
·
Antonio Belinchon
, Herminio Perez‐ Garrigues
, et al.
·
The Laryngoscope
·
65
Evolution of Symptoms in Ménière’s Disease
2011
·
Antonio Belinchon
, Herminio Perez-Garrigues
, et al.
·
Audiology and Neurotology
·
54
Evaluating the Efficacy of Intratympanic Dexamethasone in Protecting Against Irreversible Hearing Loss in Patients on Cisplatin-Based Cancer Treatment: A Randomized Controlled Phase IIIB Clinical Trial
2021
·
Inmaculada Moreno
, Antonio Belinchon
·
Ear and Hearing
·
25
Vestibulotoxicity in Patients Undergoing Cisplatin-Based Cancer Treatment: A Phase IIIB Randomized Controlled Clinical Trial
2023
·
Inmaculada Moreno
, Antonio Belinchon
·
Audiology and Neurotology
·
2
Safety of Intratympanic Dexamethasone to Treat Inner Ear Diseases
2022
·
Inmaculada Moreno
, Antonio Belinchon
·
Otorhinolaryngology Clinics - An International Journal
·
2
PDF
Resultado funcional y social de los implantes auditivos osteointegrados
2017
·
Inmaculada MORENO-ALARCÓN
, Antonio BELINCHÓN-DIEGO
·
Revista ORL
·
2
PDF
Intratympanic Dexamethasone Efficacy in Preventing Cisplatin-induced Tinnitus: A Randomized Controlled Phase IIIB Clinical Trial
2026
·
Inmaculada Moreno
, Antonio Belinchon
·
Ear and Hearing
·
1
Author Reply to Letter to the Editor Regarding “Intratympanic Dexamethasone Efficacy in Preventing Cisplatin-Induced Tinnitus: A Randomized Controlled Phase IIIB Clinical Trial”
2026
·
Inmaculada Moreno
, Antonio Belinchon
·
Ear and Hearing
Show more works
View as search
Works count:
8
Citation count:
151
H-index:
3
I10-index:
3
Year
Topic
Type